11/13/2024
3:16 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/20/2024
4:41 PM | Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2024
4:42 PM | Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
4:45 PM | Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2024
4:47 PM | Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/28/2024
3:35 PM | Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/28/2024
3:37 PM | Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:16 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:00 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
TETLOW SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | DOBMEIER ERIC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
Waldstreicher Joanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
7:19 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:07 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/12/2024
3:42 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:07 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
6:38 PM | Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:43 PM | Structure Therapeutics (Filer)
| Form S-1MEF | |
06/03/2024
7:00 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
5:57 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G | |
05/09/2024
3:56 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:10 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
4:24 PM | Structure Therapeutics (Filer)
| Form ARS | |
04/19/2024
1:13 PM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:34 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:37 PM | Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
| Form 4/A | |
03/20/2024
6:39 PM | Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:41 PM | Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:42 PM | Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/19/2024
3:36 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:52 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:19 PM | Structure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024
8:19 AM | Structure Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:43 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:11 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad) Coins Set to Soar with a Pro-Crypto White House
President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets… Click here to reserve your free seat at the Crypto Community Summit |
02/14/2024
8:07 AM | Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:45 AM | Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
6:59 AM | FIL Ltd (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
10:01 AM | Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
12/27/2023
9:49 AM | Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:49 AM | FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:36 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
12/18/2023
7:28 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
10:04 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
11/17/2023
4:25 PM | Structure Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/17/2023
3:51 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
11/17/2023
3:55 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023
4:13 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
